In Washington’s debate over enacting steep funding cuts to Medicaid, words are a central battleground.
The FDA Accepts MDMA for PTSD Therapy’s New Drug Application | Psychedelic Invest
The U.S. Food and Drug Administration (FDA) has recently approved a groundbreaking New Drug Application (NDA) submitted by Lykos Therapeutics for MDMA-assisted therapy in the
February 12, 2024